MedPath

Efficacy of combined topical treatment versus cryotherapy for the treatment of refractory warts

Phase 3
Recruiting
Conditions
Hand and foot wart.
Plantar wart
B07.0
Registration Number
IRCT20221109056452N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Treatment-resistant warts
Consent to participate in the study

Exclusion Criteria

Pregnant and lactating women
Children under four years old
People over 65 years old
Patients under immunosuppressive treatment
Patients with immunodeficiency and hypersensitivity reactions
Patients with vascular diseases
Patients with Raynaud's phenomenon
Patients with capillary filling more than two seconds
Patients with rheumatological disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effectiveness of treatment according to the physician. Timepoint: 4 and 8 weeks after intervention. Method of measurement: Physician global assessment.;Effectiveness of treatment according to the patient. Timepoint: 4 and 8 weeks after intervention. Method of measurement: Patient global assessment.;Local pain. Timepoint: 4 and 8 weeks after intervention. Method of measurement: Visual analogue scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath